Table 6 Characterization of PHA produced in the accumulation stage of Trial 2 compared with commercial PHA88/12
Products | HB/HVa (molar ratio) | Mwb (kDa) | Polydispersity | Rhc (nm) | a d | logK d |
|---|---|---|---|---|---|---|
Commercial reference—PHA88/12 | 90/10 | 2∙105 | 1.3 | 14 | 0.70 | −3.8 |
Extracted PHA from Trial 2 | 53/47 | 8∙105 | 1.4 | 29 | 0.65 | −3.4 |